The role Billy Gilmour could play in Chelsea and Manchester United’s Declan Rice transfer battle

Declan Rice has been subject of interest from Premier League rivals Manchester United and Chelsea, but where will he end up if he decides to leave West Ham?

The West Ham United midfielder only signed a new contract at the London Stadium in December 2018 but has attracted interest from the two English giants.

Rice has been an ever-present figure in the Hammers’ team this season, making 35 appearances across all competitions.

The 21-year-old could be an ideal long-term replacement for Nemanja Matic, who has reportedly been offered a new two-year deal at Old Trafford.

Video Loading

Video Unavailable

Click to play
Tap to play

The video will start in8Cancel

Play now

United boss Ole Gunnar Solskjaer confirmed earlier this month that the 31-year-old would stay at the Manchester club but an official deal is yet to be announced.

Matic has been an integral part of United’s midfield over the years and Rice could be the younger option to replace the Serbian.

The England international has impressed over the past three seasons, with his defensive abilities as well as his calmness and composure in possession.

Read More
Related Articles
Read More
Related Articles

As it stands, Solskjaer has Fred, Scott McTominay, Paul Pogba and Matic to choose from for his central midfield options.

Pogba’s future at Old Trafford remains uncertain and Rice could be the perfect candidate to play alongside Fred or McTominay.

However, a move to Chelsea would see him join the likes of Jorginho and Billy Gilmour, who both can play in Rice’s position.

This is your round up of all things West Ham United; the one-stop shop that will keep you updated on the latest goings on at the London Stadium and beyond. 

Transfers, injuries, match-days and managers, we’ve got you covered. 

We’ll be bringing the very latest on the Irons throughout week and around the clock. 

Make sure you keep yourself updated with our handy daily catch up…

Must reads Injury latest as…